Lataa...
The impact and cost-effectiveness of nonavalent HPV vaccination in the United States: Estimates from a simplified transmission model
Introduction: The objective of this study was to assess the incremental costs and benefits of the 9-valent HPV vaccine (9vHPV) compared with the quadrivalent HPV vaccine (4vHPV). Like 4vHPV, 9vHPV protects against HPV types 6, 11, 16, and 18. 9vHPV also protects against 5 additional HPV types 31, 33...
Tallennettuna:
| Julkaisussa: | Hum Vaccin Immunother |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Taylor & Francis
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4964746/ https://ncbi.nlm.nih.gov/pubmed/26890978 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2016.1140288 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|